SynthesisPancreas2017

Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer?

Ramya Thota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.